Hot on the heels of its block-buster mRNA gene therapy for COVID, Moderna is planning to use the technology to roll out a Lyme disease jab soon.
Company CEO Stéphane Bancel, announced the project in a quarterly newsletter that also revealed plans for a norovirus and flu vaccine. The Lyme disease shot will be Moderna’s first bacterial vaccine.
"Our mRNA platform has changed medicine and will continue to have a major impact on global health. Today we are excited to announce multiple new vaccine candidates, including for enteric viruses, such as norovirus, and targeting Lyme disease, our first bacterial vaccine," Bancel said.
“With our mRNA platform and technology, as well as our agile manufacturing capabilities, we are confident that we can quickly develop safe and effective vaccines to address critical unmet needs."
SOURCES:
Moderna April 11, 2023
Yahoo! April 12, 2023